Robert Califf

Robert Califf is a cardiologist currently serving a second term as Commissioner of the Food and Drug Administration. He was first nominated by President Obama in 2015, and brought back as FDA commissioner in 2021 by President Biden. He’s also known for his work on Google Health initiatives, including Verily Life Sciences; his well-cited history as a medical author and researcher, and his sometimes controversial connections with the pharmaceutical industry.

All Coverage

Politics Sheila Kaplan

Senate vote on Robert Califf may put him back on track for top FDA job

Politics Dylan Scott

Massachusetts senator faults FDA for not consulting with outside experts on opioid approvals

Politics Sheila Kaplan

FDA to overhaul opioid policies. Will it ease concerns over Califf?

Politics David Nather

Opposition to FDA’s Robert Califf grows as senator threatens filibuster

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: More Robert Califf opposition, J&J settling thousands of lawsuits

Politics Sheila Kaplan

STAT Plus: Bernie Sanders says he’ll block Senate vote on FDA’s Robert Califf

Politics Mark Arsenault — Boston Globe

STAT Plus: Ed Markey blocks vote on FDA chief over opiate approvals

Politics Sheila Kaplan

Califf wins Senate panel vote, but faces trouble on food labeling

Pharmalot Ed Silverman

STAT Plus: Drug pricing will continue to loom large for pharma in 2016

Pharmalot Ed Silverman

STAT Plus: J&J blood thinner under review for trial overseen by FDA nominee Califf

Politics Sheila Kaplan

Califf: I’ll never lower FDA’s approval standards

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Califf’s FDA hearing, blood cancer drug approval

Politics Sheila Kaplan

What to expect from FDA nominee Robert Califf’s confirmation hearing

Politics Ed Silverman

Most Read

Califf’s big idea: Build a database for research done before clinical trials

FDA chief aims to recruit 100 million Americans for precision medicine research

STAT Plus: Lawmakers accuse HHS of delaying FDA guidelines for off-label marketing

Califf: FDA can’t isolate itself from industry, despite ‘touchy’ issues

FDA to require stronger warnings on some prescription painkillers

Pharmalot, Pharmalittle: FDA to focus on generics, opioid crisis

Senate confirms Robert Califf as new FDA chief, ending battle for top job

Senate vote removes major hurdle in Robert Califf’s bid to lead FDA

All Coverage

Senate vote on Robert Califf may put him back on track for top FDA job

Massachusetts senator faults FDA for not consulting with outside experts on opioid approvals

FDA to overhaul opioid policies. Will it ease concerns over Califf?

Opposition to FDA’s Robert Califf grows as senator threatens filibuster

Pharmalot, Pharmalittle: More Robert Califf opposition, J&J settling thousands of lawsuits

STAT Plus: Bernie Sanders says he’ll block Senate vote on FDA’s Robert Califf

STAT Plus: Ed Markey blocks vote on FDA chief over opiate approvals

Califf wins Senate panel vote, but faces trouble on food labeling

STAT Plus: Drug pricing will continue to loom large for pharma in 2016

STAT Plus: J&J blood thinner under review for trial overseen by FDA nominee Califf

Califf: I’ll never lower FDA’s approval standards

Pharmalot, Pharmalittle: Califf’s FDA hearing, blood cancer drug approval

What to expect from FDA nominee Robert Califf’s confirmation hearing

FDA nominee Robert Califf must prove his independence from industry

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!